All In MedTech

Device Trial Radar · NCT01091883

Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma

Phase IIIA Study Comparing the Safety and Effectiveness of MR Guided Focused Ultrasound and External Beam Radiation for Treatment of Metastatic Bone Tumors and Multiple Myeloma

Last checked: Nov 20, 2026Latest source record: Mar 13, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

May 2010

Primary completion

Jan 2019

Study completion Mar 2019

Sponsor

Lead sponsor
InSightecNot on our public-company list
Sponsor type
Industry
First posted
Mar 24, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to collect comparative data on safety and efficacy of MR Guided Focused Ultrasound and External Beam Radiation for treatment of metastatic bone tumors or multiple myeloma.

Conditions

  • Bone Cancer
  • Bone Metastases
  • Pain

Interventions

  • Exablate treatmentDevice

    MR Guided Focused Ultrasound

  • RadiationRadiation

    External Beam Radiation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of treatmentTime frame: 6 months
  2. NRS scoreTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Taipei Medical University Hospital

    Taipei City, Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.